Expedia Group, Inc. (EXPE) Stock Forecast
Data as of Jun 16, 2026Consumer Cyclical · Current price $244.86 (+3.37%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 27, 2026 | Brian Nowak | Morgan Stanley | $290.00 | +18.4% |
| Feb 17, 2026 | Shyam Patil | Susquehanna | $240.00 | -2.0% |
| Feb 17, 2026 | Brian Pitz | BMO Capital | $255.00 | +4.1% |
| Feb 13, 2026 | Ken Gawrelski | Wells Fargo | $315.00 | +28.6% |
| Feb 10, 2026 | Gregory Miller | Truist Financial | $252.00 | +2.9% |
| Jan 21, 2026 | Trevor Young | Barclays | $245.00 | +0.1% |
| Jan 6, 2026 | Richard Clarke | Bernstein | $256.00 | +4.5% |
| Nov 17, 2025 | Tom White | D.A. Davidson | $294.00 | +20.1% |
| Nov 14, 2025 | Lloyd Walmsley | Mizuho Securities | $270.00 | +10.3% |
| Aug 11, 2025 | Shyam Patil | Susquehanna | $200.00 | -18.3% |
| Aug 11, 2025 | Richard Clarke | Bernstein | $210.00 | -14.2% |
| Aug 11, 2025 | Tom White | D.A. Davidson | $218.00 | -11.0% |
| Aug 10, 2025 | Richard Clarke | Bernstein | $215.00 | -12.2% |
| Aug 8, 2025 | Jake Fuller | BTIG | $250.00 | +2.1% |
| Aug 8, 2025 | Thomas Champion | Piper Sandler | $190.00 | -22.4% |
| Aug 8, 2025 | Ken Gawrelski | Wells Fargo | $211.00 | -13.8% |
| Jul 23, 2025 | Deepak Mathivanan | Cantor Fitzgerald | $200.00 | -18.3% |
| Apr 7, 2025 | Ken Gawrelski | Wells Fargo | $143.00 | -41.6% |
| Jan 13, 2025 | Trevor Young | Barclays | $166.00 | -32.2% |
| Nov 18, 2024 | Tom White | D.A. Davidson | $190.00 | -22.4% |
Top Analysts Covering EXPE
EXPE vs Sector & Market
| Metric | EXPE | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.52 | 2.41 |
| Analyst Count | 40 | 13 | 19 |
| Target Upside | +20.4% | +387.3% | +17.1% |
| P/E Ratio | 20.69 | 13.92 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $15.66B | $15.96B | $16.18B | 26 |
| 2027-03-31 | $3.40B | $3.57B | $3.67B | 9 |
| 2027-06-30 | $4.20B | $4.40B | $4.54B | 9 |
| 2027-09-30 | $4.78B | $5.01B | $5.17B | 14 |
| 2027-12-31 | $3.88B | $4.06B | $4.19B | 9 |
| 2028-03-31 | $3.78B | $3.96B | $4.08B | 8 |
| 2028-06-30 | $4.78B | $5.01B | $5.16B | 11 |
| 2028-09-30 | $5.31B | $5.57B | $5.74B | 8 |
| 2028-12-31 | $4.33B | $4.54B | $4.68B | 8 |
| 2029-12-31 | $19.32B | $19.72B | $20.38B | 14 |
| 2030-12-31 | $19.93B | $20.34B | $21.02B | 8 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $16.98 | $19.47 | $20.63 | 18 |
| 2027-03-31 | $1.77 | $1.89 | $1.96 | 5 |
| 2027-06-30 | $5.70 | $6.07 | $6.31 | 5 |
| 2027-09-30 | $9.14 | $9.73 | $10.11 | 5 |
| 2027-12-31 | $5.12 | $5.45 | $5.67 | 5 |
| 2028-03-31 | $2.96 | $3.15 | $3.28 | 7 |
| 2028-06-30 | $7.58 | $8.07 | $8.39 | 6 |
| 2028-09-30 | $11.13 | $11.84 | $12.31 | 6 |
| 2028-12-31 | $6.80 | $7.23 | $7.52 | 7 |
| 2029-12-31 | $29.96 | $30.77 | $32.11 | 6 |
| 2030-12-31 | $32.56 | $33.44 | $34.89 | 6 |
Frequently Asked Questions
What is the analyst consensus for EXPE?
The consensus among 40 analysts covering Expedia Group, Inc. (EXPE) is Hold with an average price target of $271.56.
What is the highest price target for EXPE?
The highest price target for EXPE is $315.00, set by Ken Gawrelski at Wells Fargo on 2026-02-13.
What is the lowest price target for EXPE?
The lowest price target for EXPE is $75.00, set by Tom White at D.A. Davidson on 2024-02-09.
How many analysts cover EXPE?
40 analysts have issued ratings for Expedia Group, Inc. in the past 12 months.
Is EXPE a buy or sell right now?
Based on 40 analyst ratings, EXPE has a consensus rating of Hold (2.67/5) with a +20.4% upside to the consensus target of $271.56.
What are the earnings estimates for EXPE?
Analysts estimate EXPE will report EPS of $19.47 for the period ending 2026-12-31, with revenue estimated at $15.96B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.